• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Renalytix PLC (RENX)

ORD 0.25P
Sell: 7.50p|Buy: 8.50p|Change: 0 (0%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Company profile

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Address

19 Stanwell Road
Avon House
Cardiff
GBR
CF64 2EZ

Website

https://www.renalytix.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Renalytix PLC Second Quarter Earnings Conference Call for 20262026-03-18T14:00:00
Renalytix PLC Second Quarter Earnings Results for 20262026-03-18T00:00:00
Renalytix PLC Annual General Meeting for 20252025-12-19T11:00:00
Renalytix PLC First Quarter Earnings Results for 20262025-11-20T00:00:00
Renalytix PLC First Quarter Earnings Conference Call for 20262025-11-20T00:00:00
Renalytix PLC Fourth Quarter Earnings Results for 20252025-10-01T00:00:00
Renalytix PLC Fourth Quarter Earnings Conference Call for 20252025-10-01T00:00:00
Renalytix PLC Annual Report for 20252025-09-30T00:00:00
Renalytix PLC Third Quarter Earnings Conference Call for 20252025-05-15T08:30:00
Renalytix PLC Third Quarter Earnings Results for 20252025-05-15T00:00:00

Previous key dates

NameKey Date
Renalytix PLC Second Quarter Earnings Conference Call for 20252025-03-18T14:00:00
Renalytix PLC Second Quarter Earnings Result for 20252025-03-18T00:00:00
Renalytix PLC Annual General Meeting for 20242024-12-19T11:00:00
Renalytix PLC First Quarter Earnings Result for 20252024-11-20T00:00:00
Renalytix PLC First Quarter Earnings Conference Call for 20252024-11-20T00:00:00
Renalytix PLC Fourth Quarter Earnings Result for 20242024-10-01T00:00:00
Renalytix PLC Fourth Quarter Earnings Conference Call for 20242024-10-01T00:00:00
Renalytix PLC Annual Report for 20242024-09-30T00:00:00
Renalytix PLC Third Quarter Earnings Conference Call for 20242024-05-15T08:30:00
Renalytix PLC Third Quarter Earnings Result for 20242024-05-15T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.